Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 17, 2021

SELL
$42.19 - $51.5 $168,760 - $206,000
-4,000 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$35.33 - $51.04 $35,330 - $51,040
-1,000 Reduced 20.0%
4,000 $204,000
Q2 2020

Aug 13, 2020

BUY
$22.91 - $39.83 $114,550 - $199,150
5,000 New
5,000 $176,000
Q3 2019

Nov 06, 2019

SELL
$26.92 - $42.41 $134,600 - $212,049
-5,000 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$18.54 - $40.97 $92,700 - $204,850
5,000 New
5,000 $205,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.42B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.